Elisabeth Bik | |
---|---|
Born | Elisabeth Margaretha Bik 1966 (age 57–58) |
Alma mater | Utrecht University (MSc, PhD) |
Scientific career | |
Institutions | |
Thesis | Cholera: vaccine development and evolution of epidemic Vibrio cholerae strains (1996) |
Notes | |
Elisabeth Margaretha Harbers-Bik (born 1966) is a Dutch microbiologist and scientific integrity consultant. [1] Bik is known for her work detecting photo manipulation in scientific publications, [2] [3] [4] and identifying over 4,000 potential cases of improper research conduct. [5] Bik is the founder of Microbiome Digest, [6] a blog with daily updates on microbiome research, and the Science Integrity Digest blog. [7] [8]
Bik was awarded the 2021 John Maddox Prize for "outstanding work exposing widespread threats to research integrity in scientific papers". [9]
Bik was born in the Netherlands. Since childhood, she had a good ability to spot repeating patterns. [10] She studied at the Utrecht University, where she obtained her MSc degree and subsequently a PhD in 1996, both in microbiology. Her dissertation was about developing vaccines for new strains of Vibrio cholerae involved in cholera epidemics across India and Bangladesh. [11] [12] [13] [14] She conducted her doctorate and her postdoctoral studies at the molecular microbiology department in the National Institute of Health and the Environment in Bilthoven. [15]
After receiving her doctorate, Bik worked for the Netherlands National Institute for Public Health and the Environment and St. Antonius Hospital in Nieuwegein, where she organized the development of new molecular techniques for identifying infectious agents. [16] [17]
In 2001, Bik moved to California to work at Stanford University in the laboratory of David Relman, where her work focused on human microbiomes, previously unidentified microbial species in them, and their diversity across individuals. [18] [19] Her work explored other mucosal microbiomes, confirming that the human oral microbiota contains distinct genera from the gut microbiota. [20]
While at Stanford, Bik worked on an Office of Naval Research project to study the microbiome of dolphins and sea lions in San Diego. She found that their microbiome was distinct from other mammals, and influenced by the sea they lived in. [21]
In 2016, Bik left Stanford to work for uBiome, a biotech company involved in the sequencing of human microbiomes, before leaving the company in 2018 to work full-time on analyzing scientific papers for image duplication and other malpractices. [14]
Bik started to focus on science integrity in 2013, when she discovered that one of her publications had been plagiarised. [22] One evening in January 2014, she found duplicated images with manipulations in papers from Case Western Reserve University School of Medicine. [10] She decided to dedicate her free time to looking for questionable practices in scientific publications, and specialized in tracking down image manipulation in studies.
In 2014, she started the blog Microbiome Digest, where she provided easy-to-understand commentaries on recent scientific papers. [23] The blog soon became a success, and Bik enlisted help from her colleagues on Twitter to manage the content. [23] She is also an active contributor to Retraction Watch [4] and PubPeer, [24] highlighting scientific papers that present falsified, duplicated, and questionable data, such as in western blot images.
Together with Arturo Casadevall and Ferric Fang, Bik published an mBio paper investigating the prevalence of these questionable practices within published scientific papers, where they found nearly 400 papers with intentional figure manipulation (i.e. about 800 duplicate images). [25] She estimates half of these were created with the intention to mislead. Bik is active on Twitter, where she posts potentially duplicated figures for her more than 114,000 followers (as of November 2021 [update] ) to investigate. Her investigations have exposed significant levels of scientific misconduct in several journals. [14] In 2018, Bik was featured on the pop science podcast "Everything Hertz." [26]
In 2019, Bik announced via Twitter that she was taking a year off paid work to investigate scientific misconduct, [23] [27] [28] the subject on which she co-authored a preregistered test suggesting that "academic culture, peer control, cash-based publication incentives and national misconduct policies", but not pressure to publish, may affect scientific integrity, with nationality being a stronger predictor than individual attributes. [29] Her analysis of 960 recent papers published in Molecular and Cellular Biology found that 59 (6.1%) contained inappropriately duplicated images, from which 5 papers were subsequently retracted and 41 papers had corrections published, and led to a pilot image screening program at the journal identifying problems with 14.5% of subsequent submissions. [30]
In February 2020, Science reported that Bik had identified over 400 research papers published in China over the previous three years, apparently all originating from the same research paper mill company providing full service production of articles describing fake research for medical students on demand. [31] Bik said, "students in China need to have a paper published to get their MD, but they do not have time to do research, so that is an unrealistic goal." [32]
In March 2020, commenting on the publication of the results of a clinical trial by Didier Raoult on the effect of hydroxychloroquine against COVID-19, she identified a conflict of interest and strongly criticized the methodology of the study. [33] [34] The owners of the journal that published the results admitted that the publication was not at the level expected by the society, in particular due to a lack of justification of the criteria for patient selection and triage. [35] They then rebutted allegations of a conflict of interest, stating that the peer review process prior to publication was respected because Jean-Marc Rolain, one of the co-authors of the article and editor of the journal, did not participate in the evaluation. The publisher Elsevier then announced an additional independent evaluation to determine whether the concerns about the article were well founded. [36]
On May 5, 2021, the French non profit association Citizen4Science, made up of scientists and citizens, published a press release in response to an announcement by Didier Raoult's lawyer that IHU Marseille was suing Bik. Citizen4Science linked a petition denouncing the harassment of scientists and defenders of science integrity, specifically mentioning Bik and calling on French authorities to intervene and journalists to look into the matter. [37] On May 8, 2021, Lonni Besançon, a French postdoctoral research fellow at Monash University, also wrote an open letter signed by scientists to support Bik. [38] The letter, also mentioned in The Guardian, [39] Science, [40] and Nature , [41] gathered signatures from more than 2,200 scientists and 30 scholarly societies. [42]
On May 22, 2021, The Guardian reported that Raoult had begun legal proceedings against Bik. [39] A Science article updated on June 4, 2021, in print issue 6546, stated that more than 3,000 signatories supported the Citizen4Science petition. [40]
In September 2021, Bik discovered repetitive elements in published images that indicated digital tampering by authors of a paper by the controversial Comet Research Group claiming the discovery of the Biblical Sodom, and evidence that it had been destroyed by a cosmic airburst. [43] The authors initially denied tampering with the photos but eventually published a correction in which they admitted to inappropriate image manipulation. [44] On February 15, 2023, the following editor’s note was posted on this paper, "Readers are alerted that concerns raised about the data presented and the conclusions of this article are being considered by the Editors. A further editorial response will follow the resolution of these issues". [45]
During a session of the 2022 European Hematology Association Congress, Bik presented information about artificial intelligence being used to fraudulently generate Western blot images. [46]
Scientific misconduct is the violation of the standard codes of scholarly conduct and ethical behavior in the publication of professional scientific research. It is violation of scientific integrity: violation of the scientific method and of research ethics in science, including in the design, conduct, and reporting of research.
In academic publishing, a retraction is a mechanism by which a published paper in an academic journal is flagged for being seriously flawed to the extent that their results and conclusions can no longer be relied upon. Retracted articles are not removed from the published literature but marked as retracted. In some cases it may be necessary to remove an article from publication, such as when the article is clearly defamatory, violates personal privacy, is the subject of a court order, or might pose a serious health risk to the general public.
Catherine M. Verfaillie is a Belgian molecular biologist. After obtaining an M.D. from the Catholic University of Leuven in 1982, she specialized in internal medicine in 1987. She currently she works as a biologist and a professor at KU Leuven. Her work on the ability of adult stem cells to differentiate to different cell types has garnered controversy due to accusations of poor laboratory practices and fabrication of data by members of her laboratory. In 2019, it was shown that several of her more recent papers also contained altered images and potential fraud was committed. An investigation by the KU Leuven Commission on Research Integrity, finished in July 2020, concluded that there was no breach of research integrity in the investigated publications, but that some papers did contain inaccurate figures.
Academic authorship of journal articles, books, and other original works is a means by which academics communicate the results of their scholarly work, establish priority for their discoveries, and build their reputation among their peers. Through authorship, researchers, assistants, interns, students, and other involved parties receive credit for their contributions and can be held responsible and accountable for the quality and integrity of the work.
Didier Raoult is a retired French physician and microbiologist specialising in infectious diseases. He taught about infectious diseases at the Faculty of Medicine of Aix-Marseille University (AMU), and in 1984, created the Rickettsia Unit of the university. From 2008 to 2022, Raoult was the director of the Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes. He gained significant worldwide attention during the COVID-19 pandemic for vocally promoting hydroxychloroquine as a treatment for the disease, despite lack of evidence for its effectiveness and the subsequent opposition from NIH and WHO to its use for the treatment of COVID-19 in hospitalized patients.
Carlo Maria Croce is an Italian-American professor of medicine at Ohio State University, specializing in oncology and the molecular mechanisms underlying cancer. Croce and his research have attracted public attention because of multiple allegations of scientific misconduct.
The Ingelfinger rule is an eponymous rule named after Franz J. Ingelfinger, the The New England Journal of Medicine (NEJM) editor-in-chief who enunciated it in 1969. Editorials in most journals were published anonymously that time, so the paper was published without an author's name.. This rule - basically meant for scientific publishing, was originally meant only for NEJM. The rule was, that NEJM would not publish findings that had been published elsewhere, in other media or in other journals. The rule was subsequently adopted by several other scientific journals, and has shaped scientific publishing ever since. Historically it has also helped to ensure that the journal's content is fresh and does not duplicate content previously reported elsewhere, and seeks to protect the scientific embargo system.
Retraction Watch is a blog that reports on retractions of scientific papers and on related topics. The blog was launched in August 2010 and is produced by science writers Ivan Oransky and Adam Marcus. Its parent organization is the Center for Scientific Integrity, a US 501(c)(3) nonprofit organization.
Research integrity or scientific integrity is an aspect of research ethics that deals with best practice or rules of professional practice of scientists.
Haruko Obokata is a former stem-cell biologist and research unit leader at Japan's Laboratory for Cellular Reprogramming, Riken Center for Developmental Biology. She claimed in 2014 to have developed a radical and remarkably easy way to generate stimulus-triggered acquisition of pluripotency (STAP) cells that could be grown into tissue for use anywhere in the body. In response to allegations of irregularities in Obokata's research publications involving STAP cells, Riken launched an investigation that discovered examples of scientific misconduct on the part of Obokata. Attempts to replicate Obokata's STAP cell results failed. The ensuing STAP cell scandal gained worldwide attention.
Karen Nelson is a Jamaican-born American microbiologist who was formerly president of the J. Craig Venter Institute (JCVI). On July 6, 2021 she joined Thermo Fisher Scientific as Chief Scientific Officer.
Annarosa Leri is a medical doctor and former associate professor at Harvard University. Along with former professor Piero Anversa, Leri was engaged in biomedical research at Brigham and Women’s Hospital in Boston, an affiliate of Harvard Medical School. Since at least 2003 Anversa and Leri had investigated the ability of the heart to regenerate damaged cells using cardiac stem cells.
Arturo Casadevall is a Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, and the Alfred and Jill Sommer Professor and Chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He is an internationally recognized expert in infectious disease research, with a focus on fungal and bacterial pathogenesis and basic immunology of antibody structure-function. He was elected a member of the National Academy of Sciences in 2022.
David Arnold Relman is an American microbiologist and the Thomas C. and Joan M. Merigan Professor in Medicine, and in Microbiology & Immunology at the Stanford University School of Medicine. His research focuses on the human microbiome and microbial ecosystem—for which he was a pioneer in the use of modern molecular methods, as well as on pathogen discovery and the genomics of host response.
Ferric C. Fang is an American microbiologist. He is a Professor of Laboratory Medicine, Pathology, and Microbiology at the University of Washington School of Medicine, as well as the director of the Harborview Medical Center's Clinical Microbiology Laboratory. Prior to joining the University of Washington in 2001, he taught at the University of Colorado School of Medicine. From 2007 to 2017, he was the editor-in-chief of Infection and Immunity, and he was the deputy editor of Clinical Infectious Diseases from 2016 to 2021. He is currently an editor of Clinical Microbiology Reviews. He has been a member of the American Society for Clinical Investigation since 1998, as well as an elected Fellow of the American Academy of Microbiology and the American Association for the Advancement of Science.
Joyoti Basu is an Indian biochemist, cell biologist and a senior professor at the Bose Institute. Known for her studies on the membrane structure of red blood cells, Basu is an elected fellow of all three major Indian science academies, namely the National Academy of Sciences, India, the Indian Academy of Sciences and the Indian National Science Academy, as well as the Indian Society for Chemical Biology. The Department of Biotechnology of the Government of India awarded her the National Bioscience Award for Career Development, one of the highest Indian science awards, for her contributions to biosciences in 2002.
Fermentibacteria is a bacterial phylum with candidate status. It is part of the FCB group.
Delphibacteria is a candidate bacterial phylum in the FCB group. The phylum was first proposed after analysis of two genomes from the mouths of two bottlenose dolphins. "Dephibacteria" was proposed in recognition of the first genomic representatives having been recovered from the dolphin mouth. Members of the Delphibacteria phylum have been retroactively detected in a variety of environments.
Sapan Sharankishor Desai is an American ex-physician, and the owner of Surgisphere, originally a textbook marketing company that claimed to provide large sets of medical data on COVID-19 patients. This data and the research using it has been discredited, and two papers Desai co-authored that used this data were retracted after being published in prominent medical journals.
{{cite web}}
: CS1 maint: others (link)